Rigel launches Phase II trial to assess fostamatinib for Covid-19
Rigel Pharmaceuticals has launched a Phase II clinical trial to test the safety of fostamatinib to treat hospitalised Covid-19 patients.…
Latest News
-
3 days
-
3 days
-
3 days
-
4 days
-
4 days
-
4 days
-
5 days
-
5 days
Roche’s Actemra reduces need for mechanised ventilation in Covid-19 patients
Roche has reported that its Actemra/RoActemra (tocilizumab) reduced the need for mechanical ventilation in hospitalised Covid-19 patients with associated pneumonia…
Latest News
View More
Lilly reports Covid-19 antibody reduced rate of hospitalisation
Eli Lilly has reported positive proof-of-concept results from the BLAZE-1 clinical trial, which assessed SARS-CoV-2 neutralising antibody candidate LY-CoV555, to treat symptomatic Covid-19 in outpatients.…
OPKO Health evaluates Rayaldee to treat Covid-19 patients
Biopharmaceutical company OPKO Health has launched a Phase II clinical trial to assess Rayaldee as a potential treatment for mild to moderate Covid-19. The drug…
Daiichi Sankyo to test patritumab deruxtecan for colorectal cancer
Daiichi Sankyo has started dosing patients in a Phase II clinical trial of patritumab deruxtecan (U3-1402) for the treatment of…
Pfizer says Covid-19 vaccine showed moderate side effects
Pfizer has said that Phase III clinical trial participants were experiencing mild-to-moderate side effects with its investigational Covid-19 vaccine candidate.…
Boehringer’s drug improves cognition in Phase II schizophrenia trial
Boehringer Ingelheim has announced that BI 425809 has improved cognition in stable adults with schizophrenia in a Phase II clinical…
Imperial College team to assess inhaled Covid-19 vaccines
Imperial College London is set to conduct small clinical trials of inhaled versions of Covid-19 vaccines developed by researchers and…
Company A-Z
View More
Jeeva Informatics Solutions
Artificial Intelligence (AI)-Driven Decentralised Clinical Trial Development
Latest Content
View More
Vaxart secures FDA clearance to trial Covid-19 vaccine candidate
Biotechnology firm Vaxart has received clearance from the US Food and Drug Administration (FDA) to conduct a Phase I clinical…
Lilly says Reyvow provided pain freedom in Phase III migraine trial
Eli Lilly has reported that Reyvow (lasmiditan) C-V, a tablet for migraine, helped patients to be pain-free at 60 minutes…
MELACTOPLAN
A natural product without any side effects; for stress, anxiety, sleep or jet-lag. Melactoplan promotes relaxation and sleep due to…
ONUREG (azacitidine) for the Treatment of Acute Myeloid Leukaemia (AML)
ONUREG® (azacitidine) is the first and only US Food and Drug Administration (FDA)-approved drug indicated for the continued treatment of…
Jeeva’s Decentralized Clinical Trials
Our Jeeva Clinical cloud-based software provides a seamless solution that improves the experience of investigators and patients by decentralizing clinical…
Patented Extracts, Amino Acids and Enzymes for Manufacturing Natural Plant-Based Products
Our best own-brand product selection to the highest quality plant extracts.